New aspects in the clinical course of pityriasis versicolor

An Bras Dermatol. 2011 Nov-Dec;86(6):1135-40. doi: 10.1590/s0365-05962011000600011.
[Article in English, Portuguese]

Abstract

Background: Pytiriasis versicolor is an infectious disease caused by several Malassezia species which has a tendency to become relapsing or chronic.

Objectives: This study was conducted in an attempt to investigate the clinical course of pityriasis versicolor with regard to the number of relapses after a 12-month therapy and correlate this number with isolates of Malassezia species.

Material and methods: 102 patients with clinical and laboratory diagnosis of pityriasis versicolor were monitored for 12 months to investigate the number of relapsing episodes of the disease.

Results: After appropriate treatment, pityriasis versicolor presented three types of clinical course: pityriasis versicolor without relapsing episodes (32.35%), relapsing pityriasis versicolor with one to four relapsing episodes (52.94% ) due to associated predisposing factors, and chronic pityriasis versicolor with more than four relapsing episodes (14.70%) with no relation to predisposing factors.

Conclusions: The clinical course of pityriasis versicolor varied according to the number of relapsing episodes of the disease analyzed over a period of 12 months and can be classified as follows: pityriasis versicolor with clinical and mycological clearing, relapsing pityriasis versicolor and chronic pityriasis versicolor.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Antifungal Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Ketoconazole / therapeutic use
  • Malassezia / classification
  • Malassezia / isolation & purification*
  • Male
  • Middle Aged
  • Prospective Studies
  • Recurrence
  • Sex Distribution
  • Tinea Versicolor / classification
  • Tinea Versicolor / drug therapy
  • Tinea Versicolor / prevention & control*
  • Young Adult

Substances

  • Antifungal Agents
  • Ketoconazole